ClinicalTrials.gg
Drug

Duloxetine clinical trials

Also written Cymbalta, LY248686 and Xeristar.

studies test it
275
open now
24
in phase 3
84
first study started
1996

How each study uses duloxetine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the duloxetine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
3 Aug 2004 · CYMBALTA · NDA 021427 (FDA, Drugs@FDA)
European Union
11 Aug 2004 · Yentreve · EMEA/H/C/000545 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Duloxetine
204
Duloxetine Hydrochloride
33
Duloxetine 30 MG
7
Duloxetine 60mg
6
Duloxetine 60 MG
6

Brand

Cymbalta
115
Xeristar
2
Ariclaim
1
Yentreve
1
Drizalma Sprinkle
1

Development codes

LY248686
45
NSC-744012
1

Studies by the year they started

273 studies that test it; most in 2007 (22); 1 more planned to start later

Studies that test duloxetine, by start year
YearStudies
19961
20016
20028
20039
200413
200517
200620
200722
200816
200920
201012
201112
20125
20136
20147
20158
201610
20178
20188
20194
202011
202118
20227
20238
20249
20253
20265

By phase

A phase 1/2 study counts in both.

Early Phase 1
4
Phase 1
18
Phase 2
38
Phase 3
84
Phase 4
95
No phase
44

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 106 · Other 169

Eli Lilly and Company (90) · Assiut University (8) · Rambam Health Care Campus (8) · New York State Psychiatric Institute (5) · Stanford University (4) · Massachusetts General Hospital (4) · University of Cincinnati (4) · Northwestern University (4)

Often tested with

Tested in the same studies.

Pregabalin (19) · Escitalopram (11) · Venlafaxine (7) · Paroxetine (5) · Gabapentin (4) · Fluoxetine (4) · Amitriptyline (4) · Sertraline (3)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 3 phase 3 studies under way

Duloxetine is the comparator. A study of two new drugs counts under both.

  • 1Capsaicin · Institut Cancerologie de l'Ouest · next primary completion Mar 2028
  • 1Methadone · University of British Columbia
  • 1Vortioxetine · Federico II University
Reaching primary completion within a year · 12, 1 in phase 3

Studies that test duloxetine, phase 3 first.

Studies

Open first, then newest update. How each study uses duloxetine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 275

See all 275 studies that test duloxetine →

Given beside what is tested · 19 — duloxetine is usual care or a partner of the new treatment
As the comparator · 35 — what is tested is compared with duloxetine

Showing 20 of 35.

What changed recently

From the registry's own updates since Oct 20, 2026.

Codes

What other systems call duloxetine · ClinicalTrials.gg INT006534

  • MeSH (NLM) D000068736Duloxetine HydrochlorideConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) O5TNM5N07UDULOXETINEConfirmed FDA, NLM, Wikidata
  • RxNorm 72625Confirmed FDA, Wikidata
  • Wikidata Q27116971duloxetine hydrochlorideConfirmed FDA, NLM, Wikidata
  • Wikidata Q411932(S)-duloxetineConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C65495DuloxetineOne source FDA
  • DrugBank DB00476One source Wikidata

Also registered as duloxetine hydrochloride (UNII 9044SC542W · RxNorm 476250).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.